[The characteristics of the brain cerebrosides, sulfocerebrosides and gangliosides in experimental demyelination and cerebrolysin administration]. 1991

M A Bespalova, and K Kliaich, and S P Maksimova, and L S Chaeva, and A P Mukhina

UI MeSH Term Description Entries
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002554 Cerebrosides Neutral glycosphingolipids that contain a monosaccharide, normally glucose or galactose, in 1-ortho-beta-glycosidic linkage with the primary alcohol of an N-acyl sphingoid (ceramide). In plants the monosaccharide is normally glucose and the sphingoid usually phytosphingosine. In animals, the monosaccharide is usually galactose, though this may vary with the tissue and the sphingoid is usually sphingosine or dihydrosphingosine. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1st ed)
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003711 Demyelinating Diseases Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system. Clinically Isolated CNS Demyelinating Syndrome,Clinically Isolated Syndrome, CNS Demyelinating,Demyelinating Disorders,Demyelination,Demyelinating Disease,Demyelinating Disorder,Demyelinations
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M A Bespalova, and K Kliaich, and S P Maksimova, and L S Chaeva, and A P Mukhina
January 1984, Zhurnal evoliutsionnoi biokhimii i fiziologii,
M A Bespalova, and K Kliaich, and S P Maksimova, and L S Chaeva, and A P Mukhina
January 1998, Voprosy meditsinskoi khimii,
M A Bespalova, and K Kliaich, and S P Maksimova, and L S Chaeva, and A P Mukhina
January 1982, Zhurnal evoliutsionnoi biokhimii i fiziologii,
M A Bespalova, and K Kliaich, and S P Maksimova, and L S Chaeva, and A P Mukhina
January 1980, Zhurnal evoliutsionnoi biokhimii i fiziologii,
M A Bespalova, and K Kliaich, and S P Maksimova, and L S Chaeva, and A P Mukhina
January 1991, Nervnaia sistema,
M A Bespalova, and K Kliaich, and S P Maksimova, and L S Chaeva, and A P Mukhina
January 1991, Nervnaia sistema,
M A Bespalova, and K Kliaich, and S P Maksimova, and L S Chaeva, and A P Mukhina
January 1973, Zhurnal evoliutsionnoi biokhimii i fiziologii,
M A Bespalova, and K Kliaich, and S P Maksimova, and L S Chaeva, and A P Mukhina
January 1963, Psychiatria, neurologia, neurochirurgia,
M A Bespalova, and K Kliaich, and S P Maksimova, and L S Chaeva, and A P Mukhina
January 1977, Voprosy meditsinskoi khimii,
M A Bespalova, and K Kliaich, and S P Maksimova, and L S Chaeva, and A P Mukhina
May 1957, Acta neurologica et psychiatrica Belgica,
Copied contents to your clipboard!